The pulmonary emphysema market is poised for steady growth driven by rising COPD prevalence, an aging global population, and greater diagnostic awareness. Advances in inhaled therapies, targeted ...

(StatePoint) More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This ...

PHILADELPHIA (WPVI) -- There's another disease to add to the list of smoking-related ailments. But for doctors, they are still learning about CPFE or Combined Pulmonary Fibrosis and Emphysema. For ...

The emphysema market is anticipated to grow steadily, fueled by a range of emerging therapies under development. Leading candidates like SAR447537 (Sanofi), Alvelestat (Mereo BioPharma), BEAM-302 ...

Chronic obstructive pulmonary disease is a condition caused by damage to the lungs that results in breathing difficulties.

Please provide your email address to receive an email when new articles are posted on . “We found a stepwise greater loss of lung density with increasing exacerbation frequency, predominantly in ...

CHICAGO — Hospital volume affected the length of stay for patients with COPD who elect to have endobronchial valve placement, with some association with costs as well, according to an abstract ...

In Tarrant County, patients with severe chronic obstructive pulmonary disease, COPD, now have access to a procedure that can lessen airflow blockage and improve their quality of life. KERA’s Sam Baker ...

Lung cancer screening saves lives by detecting cancer early when it is most treatable. But what many people don’t realize is that the same low-dose CT scans used to screen for lung cancer can also ...